相关实验视频
Updated: May 30, 2025
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.9K
非西方移民患者和丹麦出生的淋巴瘤患者之间的相似生存率:一项丹麦基于人口的研究
Mikkel Runason Simonsen1,2, Eva Futtrup Maksten1,3, Lasse Hjort Jakobsen1
1Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
Clinical epidemiology
|January 28, 2025
概括
这项研究发现,根据丹麦的移民身份,淋巴瘤患者的整体存活率 (OS) 没有显著差异. 绩效状况和收入等因素显示出趋势,但没有显著影响生存结果.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 淋巴瘤存活率可能受到各种临床和社会经济因素的影响.
- 了解移民人口癌症护理方面的差异对于公平的医疗保健至关重要.
研究的目的:
- 为了比较非西方移民和丹麦出生的淋巴瘤患者的整体存活率 (OS).
- 确定可能调解生存差异的临床和社会经济变量.
- 研究淋巴瘤患者的移民身份和OS之间的因果关系.
主要方法:
- 全国丹麦队列研究 (2000-2020年),包括540名非西方患者和16294名丹麦出生的患者.
- 利用逆概率权重和自然效应的考克斯模型进行调解分析.
- 检查了整体存活率和亚型特定分析.
主要成果:
- 在非西方移民和丹麦出生的淋巴瘤患者 (HR:0.94 [0.79-1.12]) 之间没有观察到OS的总体显著差异.
- 通过绩效状况和收入介导的间接影响显示出移民的劣质OS趋势 (HRs: 1.06 [0.99-1.14]).
- 在经典的霍奇金淋巴瘤中注意到了一个例外,在那里观察到差异.
结论:
- 移民身份本身并没有显著影响丹麦淋巴瘤患者的整体存活率.
- 虽然绩效状况和收入显示出趋势,但它们不能完全解释生存差异.
- 这项研究强调了考虑多种因素对不同人群癌症预后的影响的重要性.
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
134
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
134
01:21Cancer Survival Analysis
324
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
324